Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhuifeng Tougu capsules is a traditional Chinese medicine (TCM) formulation approved in China for the treatment of joint diseases, including osteoarthritis and rheumatoid arthritis. Composed of 24 traditional Chinese medicinal herbs (such as Monkshood, Radix Aconiti kusnezoffii, Rhizoma Cyperi, Ligusticum wallichii, and Herba Ephedrae), it is traditionally used to dispel wind, remove dampness, dredge meridians, and relieve pain. Pharmacological studies indicate that Zhuifeng Tougu capsules exert anti-inflammatory and chondroprotective effects by inhibiting the TLR4/MyD88/NF-κB signaling pathway, thereby reducing the production of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhuifeng Tougu capsules.